STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Tevogen Bio Holdings Inc.

Filed

October 18, 2024

Period of Report

October 17, 2024

Accession Number

0001062993-24-017785